166
Views
1
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Clinical Characteristics Profile of COVID-19 Patients with Omicron Variant Admitted in a Tertiary Hospital, Central China

, &
Pages 2365-2371 | Received 09 Mar 2023, Accepted 31 May 2023, Published online: 09 Jun 2023
 

Abstract

Purpose

Omicron, a variant of COVID-19, is becoming a major issue of global concern. Its high transmissibility may bring challenges to the distribution of health care in a large population country like China. Investigating the behavior of the virus in the Chinese population will certainly help to plan for the upcoming surge of Omicron. Therefore, we made a preliminary analysis of the clinical and epidemiological characteristics of suspected cases of Omicron at the early stage of the surge.

Patients and Methods

The study was conducted in Nanyang Central Hospital, a tertiary hospital, from 21st December, 2022 to 8th January, 2023. A total of 210 patients underwent demographic characteristics and clinical symptom collection from their medical records. Moreover, sputum culture was also conducted to explore the types of bacterial or fungal infections.

Results

Our results showed that 5 patients (4.1%) were aged 16–49, 40 patients (32.5%) were aged 50–70, and 78 patients (63.4%) were aged 70 or more in the severe group. The proportion of male patients with severe diseases infected with Omicron is higher than that of female patients and the proportion of severe cases increases with age. The main symptoms of patients infected with Omicron are cough (91, 74.0%), fever (90, 73.2%), and asthma (73, 59.3%). The pathogens Streptococcus pneumoniae (71, 31.0%), Staphylococcus aureus (46, 20.1%), Mycoplasma pneumoniae (26, 11.4%), Klebsiella pneumoniae (18, 7.9%), Acinetobacter baumannii (13, 5.7%), and Haemophilus influenzae were detected in lower respiratory tract.

Conclusion

This study suggests that age >70 is a risk factor for severe COVID-19 and that patients often have bacterial or fungal infections. Our research results may help to provide effective treatment for patients with Omicron infection and also contribute to health economic analysis and research to assist future public health decision-making.

Ethical Approval

This research was approved by the Nanyang Central Hospital medical ethics committee and all patients signed an informed consent (the informed consent form of the father of a patient under the age of 18 was obtained).

Disclosure

The authors report no conflicts of interest in this work.

Additional information

Funding

There is no funding to report.